168 related articles for article (PubMed ID: 32373961)
1. MiR-802 inhibits the malignant biological behavior of oral squamous cell carcinoma by targeting proto-oncogene MET.
Xu HY; Dai Q; Chen QX; Xiao F; Dai YH
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4255-4262. PubMed ID: 32373961
[TBL] [Abstract][Full Text] [Related]
2. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
5. Micro-ribonucleic acid 143 (MiR-143) inhibits oral squamous cell carcinoma (OSCC) cell migration and invasion by downregulation of phospho-c-Met through targeting CD44 v3.
Xu P; Li Y; Yang S; Yang H; Tang J; Li M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jul; 120(1):43-51. PubMed ID: 25953639
[TBL] [Abstract][Full Text] [Related]
6. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
[TBL] [Abstract][Full Text] [Related]
7. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
He B; Lin X; Tian F; Yu W; Qiao B
J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis.
Chen ZF; Wang Y; Sun LL; Ding SY; Jinag H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5436-5445. PubMed ID: 32495922
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-224, negatively regulated by c-jun, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting ADAM17 in oral squamous cell carcinoma.
Lu Y; Huang W; Chen H; Wei H; Luo A; Xia G; Deng X; Zhang G
J Cell Mol Med; 2019 Aug; 23(8):4913-4920. PubMed ID: 31207072
[TBL] [Abstract][Full Text] [Related]
10. Function of miR‑152 as tumor suppressor in oral squamous cell carcinoma cells by targeting c‑MET.
Li M; Li Z; Wang X; Wang Y; Zhao C; Wang L
Oncol Rep; 2018 Mar; 39(3):1173-1180. PubMed ID: 29286169
[TBL] [Abstract][Full Text] [Related]
11. Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.
Hu S; Wang H; Yan D; Lu W; Gao P; Lou W; Kong X
Cell Cycle; 2018; 17(18):2284-2295. PubMed ID: 30252587
[TBL] [Abstract][Full Text] [Related]
12. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.
Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N
Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718
[TBL] [Abstract][Full Text] [Related]
13. MiR-503-5p functions as an oncogene in oral squamous cell carcinoma by targeting Smad7.
Fei Y; Shan W; Chen X
Histol Histopathol; 2020 Aug; 35(8):893-901. PubMed ID: 32319077
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.
Zhang H; Jiang S; Guo L; Li X
J Cell Mol Med; 2019 Apr; 23(4):2813-2821. PubMed ID: 30734471
[TBL] [Abstract][Full Text] [Related]
15. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
Tan J; Xiang L; Xu G
IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
[TBL] [Abstract][Full Text] [Related]
17. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.
Cui Z; Sun S; Liu Q; Zhou X; Gao S; Peng P; Li Q
Biochem Cell Biol; 2020 Apr; 98(2):154-163. PubMed ID: 31265790
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.
Wang X; Li GH
J Cell Physiol; 2018 Dec; 233(12):9447-9457. PubMed ID: 30136280
[TBL] [Abstract][Full Text] [Related]
20. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]